IBDEI3B4 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=HOSPITAL CARE - INITIAL^6^75
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=HOSPITAL CARE - SUBSEQUENT^7^75
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=HOSPITAL CARE - DISCHARGE^8^75
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=OBSERVATION CARE - INITIAL^9^75
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=OBSERVATION CARE - SUBSEQUENT^10^75
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=OBSERVATION CARE - DISCHARGE^11^75
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^75
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=EEF Version 2020 February^13^75
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=PROC - LID / LACRIMAL^7^76
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=PROC - LASER / CRYO^10^76
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=PROC - CORNEA / CONJ^6^76
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=MEDICATIONS^12^76
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=PROC - INJECTIONS / ALL^9^76
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=IMAGE / PHOTOS^2^76
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=REFRACT / GLASSES / CL^1^76
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=TEST - CATARACT / CORNEA^4^76
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=TEST - GLAUCOMA^3^76
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=TEST - OTHER^5^76
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=EDUCATION / COUNSELING^13^76
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=EYE SURGERY CODES^11^76
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=PROC - INJECTIONS / VEGF^8^76
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=TEST - ERG / VEP^14^76
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=LOW VISION / BLINDNESS^21^77
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=RETINA - VASCULAR^12^77
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=EYELIDS / LASHES^2^77
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=NEURO / STRABISMUS^18^77
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=ORBIT - PLASTICS^20^77
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=VITREOUS^17^77
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=ORBIT - TRAUMA^19^77
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=LACRIMAL / NLD / NEOPLASMS^3^77
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=MOST FREQUENT^1^77
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=CONJUNCTIVA / SCLERA^4^77
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=CORNEA / ULCER^5^77
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=LENS / CATARACT / POSTOP^6^77
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=IRIS / UVEITIS^7^77
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=GLAUCOMA - OPEN ANGLE^8^77
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=GLAUCOMA - CLOSED ANGLE^9^77
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=GLAUCOMA - SECONDARY^10^77
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^77
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^77
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=RETINA - MACULA^11^77
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^77
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=PMH / OTHER^22^77
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=RETINA - VEGF INJECT DX CODES^16^77
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=RETINA - DIABETIC RETINOPATHY^13^77
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=NEW PATIENT^2^78
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=ESTABLISHED PATIENT^1^78
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=CONSULTATIONS^3^78
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=BIOPSY/DEBRIDEMENT^1^79
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=I&D/ASPIRATION^4^79
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^2^79
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=SCOPES^8^79
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=EXCISION^3^79
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=MISCELLANEOUS^5^79
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=PEG TUBE^7^79
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=UNNA BOOT^9^79
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=WOUND VAC DRESSING^10^79
